biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Bidding war?

<< Previous

Bullboard Posts

Next >>

Comment by beenthereon Feb 24, 2022 9:41pm

137 Views

Post# 34460309

RE:RE:RE:RE:Bidding war?

Chrispi, if DNLI even thought that BTI could advance their programs than we would be them!
We are pocket change to them! They could even take a "flyer" in hopes it works! And they wouldn't even notice the loss if it didn't work out!

That's seems to be a regular issue here!

Keep it real and you guys are just so off base!
You make zero sense!

You (BTI) wants respect for starters have a full time CEO and make that preferably NOT the present part timer!